IRIS Accounts Production v23.3.1.45 09608798 director 1.6.22 31.5.23 31.5.23 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh096087982022-05-31096087982023-05-31096087982022-06-012023-05-31096087982021-05-31096087982021-06-012022-05-31096087982022-05-3109608798ns10:Originalns15:EnglandWales2022-06-012023-05-3109608798ns14:PoundSterlingns10:Original2022-06-012023-05-3109608798ns10:Originalns10:Director12022-06-012023-05-3109608798ns10:Original2022-06-012023-05-3109608798ns10:Original2023-05-3109608798ns10:Originalns10:PrivateLimitedCompanyLtd2022-06-012023-05-3109608798ns10:Originalns10:SmallEntities2022-06-012023-05-3109608798ns10:Originalns10:AuditExemptWithAccountantsReport2022-06-012023-05-3109608798ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-06-012023-05-3109608798ns10:SmallCompaniesRegimeForAccountsns10:Original2022-06-012023-05-3109608798ns10:Originalns10:FullAccounts2022-06-012023-05-3109608798ns10:Originalns10:RegisteredOffice2022-06-012023-05-3109608798ns10:Original2022-05-3109608798ns10:Originalns5:CurrentFinancialInstruments2023-05-3109608798ns10:Originalns5:CurrentFinancialInstruments2022-05-3109608798ns5:ShareCapitalns10:Original2023-05-3109608798ns5:ShareCapitalns10:Original2022-05-3109608798ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-05-3109608798ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-05-3109608798ns10:Original2021-06-012022-05-3109608798ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-05-3109608798ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-05-3109608798ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-05-3109608798ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-06-012023-05-31
REGISTERED NUMBER: 09608798 (England and Wales)















Financial Statements for the Year Ended 31 May 2023

for

HAZELWOOD PHARMA LAW SERVICES LIMITED

HAZELWOOD PHARMA LAW SERVICES LIMITED (REGISTERED NUMBER: 09608798)

Contents of the Financial Statements
FOR THE YEAR ENDED 31 MAY 2023










Page

Company Information 1

Chartered Accountants' Report 2

Balance Sheet 3

Notes to the Financial Statements 4


HAZELWOOD PHARMA LAW SERVICES LIMITED

Company Information
FOR THE YEAR ENDED 31 MAY 2023







DIRECTOR: Mr K E McArdle





REGISTERED OFFICE: 1 Beauchamp Court
10 Victors Way
Barnet
Hertfordshire
EN5 5TZ





REGISTERED NUMBER: 09608798 (England and Wales)





ACCOUNTANTS: BBK Partnership
Chartered Accountants
& Statutory Auditors
1 Beauchamp Court
10 Victors Way
Barnet
Hertfordshire
EN5 5TZ

Chartered Accountants' Report to the Director
on the Unaudited Financial Statements of
Hazelwood Pharma Law Services Limited


The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Hazelwood Pharma Law Services Limited for the year ended 31 May 2023 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of Hazelwood Pharma Law Services Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Hazelwood Pharma Law Services Limited and state those matters that we have agreed to state to the director of Hazelwood Pharma Law Services Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Hazelwood Pharma Law Services Limited and its director for our work or for this report.

It is your duty to ensure that Hazelwood Pharma Law Services Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Hazelwood Pharma Law Services Limited. You consider that Hazelwood Pharma Law Services Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Hazelwood Pharma Law Services Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






BBK Partnership
Chartered Accountants
& Statutory Auditors
1 Beauchamp Court
10 Victors Way
Barnet
Hertfordshire
EN5 5TZ


Date: .............................................

HAZELWOOD PHARMA LAW SERVICES LIMITED (REGISTERED NUMBER: 09608798)

Balance Sheet
31 MAY 2023

31.5.23 31.5.22
Notes £    £   
CURRENT ASSETS
Debtors 4 627 467
Cash at bank 76,032 25,344
76,659 25,811
CREDITORS
Amounts falling due within one year 5 (12,353 ) (4,278 )
NET CURRENT ASSETS 64,306 21,533
TOTAL ASSETS LESS CURRENT
LIABILITIES

64,306

21,533

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 6 64,206 21,433
SHAREHOLDERS' FUNDS 64,306 21,533

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 22 February 2024 and were signed by:





Mr K E McArdle - Director


HAZELWOOD PHARMA LAW SERVICES LIMITED (REGISTERED NUMBER: 09608798)

Notes to the Financial Statements
FOR THE YEAR ENDED 31 MAY 2023


1. STATUTORY INFORMATION

Hazelwood Pharma Law Services Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - 1 ).

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.23 31.5.22
£    £   
Other debtors 627 467

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.5.23 31.5.22
£    £   
Taxation and social security 10,095 3,216
Other creditors 2,258 1,062
12,353 4,278

6. RESERVES
Retained
earnings
£   

At 1 June 2022 21,433
Profit for the year 42,773
At 31 May 2023 64,206